Thermal-Based Laser May Treat Stress Urinary Incontinence

This article originally appeared here.
Share this content:
Thermal-Based Laser May Treat Stress Urinary Incontinence
Thermal-Based Laser May Treat Stress Urinary Incontinence

TUESDAY, Sept. 29, 2015 (HealthDay News) -- Noninvasive erbium:yttrium-aluminum-garnet (Er:YAG) laser treatment appears promising for stress urinary incontinence (SUI) in women, according to a study published online Sept. 21 in Lasers in Surgery and Medicine.

Urška B. Ogrinc, M.D., from the University of Ljubljana in Slovenia, and colleagues evaluated the noninvasive Er:YAG laser as a potential treatment strategy for 175 women (mean age, 49.7 years) with SUI (66 percent of women) and mixed UI (MUI; 34 percent).

The researchers found that based on an average of 2.5 procedures for each woman (separated by a two-month period), the Incontinence Severity Index scores decreased significantly from pretreatment levels for all severities (P < 0.001). Overall, more than three-quarters of patients diagnosed with SUI (77 percent) experienced significant improvement after laser treatment, while 34 percent of women with MUI showed no UI after one year of follow-up. Outcomes were not affected by age. No major adverse effects were reported.

"The results of our study have shown that new noninvasive Er:YAG laser could be regarded as a promising additional treatment strategy for SUI, with at least one year [of] lasting positive effects," the authors write. "On the other hand, it does not seem appropriate for treating MUI."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths